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The pentapeptide
proctolin
(Proct.; Arg-Tyr-Leu-Pro-Thr)
is
a modulatory
transmitter
found throughout
the crustacean
nervous system. No information
is available in this system,
however,
as to how the actions of this peptide are terminated. To study this issue in the crab Cancer borealis, we
incubated
exogenous
proctolin (1 O-5 M) with either the thoracic ganglion
(TG) or with conditioned
saline (CS) that had
been preincubated
with the TG. We removed
aliquots
at
standard
time points for analysis
by reverse-phase
highperformance
liquid chromatography
(HPLC). We found that
over time the proctolin peak became progresstvely
smaller,
while three novel peaks appeared
and increased
in size.
Comigration
experiments
using HPLC indicated that the major novel peak was Proct. [2-51 (Tyr-Leu-Pro-Thr),
while one
of the two minor peaks was Proct. [3-51 (Leu-Pro-Thr).
The
other minor peak appeared to be Proct. [l-2] (Arg-Tyr), based
on similar HPLC retention time to synthetic Proct. [l-2].
The
reduction
in the proctolin
peak and the increase in the Proct.
[2-51 peak was prevented
by co-incubation
of proctolin with
any one of several aminopeptidase
inhibitors
(lo-’ M). Proct.
[l-2]
and Proct. [3-51 appeared
to result from a diaminopeptidase-mediated
cleavage of proctolin. We tested whether Kterminal
cleavage functionally
inactivated
proctolin by
coapplying
proctolin (10~~ M) and individual aminopeptidase
inhibitors
(1O-5 M) to the isolated stomatogastric
ganglion
(STG). We found that these inhibitors significantly
enhanced
the proctolin
excitation
of the pyloric rhythm. Furthermore,
application
of synthetic Proct. [2-51 to the STG had no effect
unless high concentrations
(> 1 Om6M) were used, and neither
Proct. [l-2]
nor Proct. [3-51 (lOma M) influenced
the pyloric
rhythm. Our results indicate that proctolin
is enzymatically
degraded
and thereby biologically
inactivated
in the crab
nervous
system, primarily
by extracellularly
located aminopeptidase
activity.
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Considerableinformation is available regarding the presence,
synthesis, release, and postsynaptic effects of neuropeptide
transmitters (White et al., 1985; Polak and Bloom, 1987; Sossin
et al., 1989; DeLoof and Schoofs, 1990; Marder and Weimann,
1992). Less is known regarding the postreleasefate of these
peptides, and how that fate influences synaptic transmission.
Thus far, it hasbeen shownthat intact neuropeptidescan diffuse
relatively long distancesfrom their releasesites (Jan and Jan,
1982; Mayeri et al., 1985) or can be enzymatically cleaved in
the extracellular space(McKelvy and Blumberg, 1986; Isaac,
1987, 1988; Turner, 1987; Molineaux et al., 1988; Roseet al.,
1988; Squire et al., 1991).
In some systems,extracellular cleavage functionally inactivates the neuropeptide (Turner et al., 1985; Hall and Lloyd,
1990; Owenset al., 1992).This inactivation limits the duration
and distance over which the peptide influences its targets
(Sigvardt et al., 1986).Sometimes,however, enzymatic cleavage
either activates or enhancesthe physiologicaleffects of the peptide (Turner et al., 1985; Thorsett and Wyvratt, 1987; Owens
et al., 1992).While someinformation is available regardinghow
neuropeptide inactivation influencespeptidergic effects at both
the cellular (Sigvardt et al., 1986; Owens et al., 1992) and the
behavioral level (Turner et al., 1985; Sullivan et al., 1988; Hall
and Lloyd, 1990) little is known about the role played by neuropeptide inactivation in sculpting peptidergic modulation of
neural network activity.
One well-studied model system for neuropeptide actions on
rhythmically active networks is the crustaceanstomatogastric
nervous system (STNS; Harris-Wanick et al., 1992b; Marder
and Weimann, 1992; Weimann et al., 1993). One particularly
well-characterized rhythmic motor pattern in this systemis the
pyloric rhythm, generatedby a neural network in the stomatogastric ganglion(STG; Selverston and Moulins, 1987; HarrisWarrick et al., 1992a).The pyloric rhythm is influencedby many
different modulatory transmitters, including at leastsix different
neuropeptides(Harris-Warrick et al., 1992b; Marder and Weimann, 1992). Among the best-characterized neuropeptidesin
the STNS is the pentapeptide proctolin (Proct.; Arg-Tyr-LeuPro-Thr; Marder et al., 1986), which is also found throughout
the crustaceanCNS (Schwarz et al., 1984; Siwicki and Bishop,
1986). Exogenouslyapplied proctolin causesa dose-dependent
excitation of the pyloric rhythm (Marder et al., 1986; Hooper
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and Marder, 1987; Nusbaum and Marder, 1989a,b; Golowasch
and Marder, 1992). Within the STNS, proctolin is found in the
STG neuropil, in several fibers entering the STG, and in somata
in the neighboring commissural (COGS) and esophageal (OG)
ganglia. In the crab Cancer borealis there appear to be only three
pairs of proctolin-containing neurons that innervate the STG
iColeman et al., 1992). Th; includes the paired modulatory
proctolin neuron (MPN; Nusbaum and Marder, 1989a,b) and
the paired modulatory commissuralneuron 1 (MCNl; Christie
et al., 1993). Both of these neurons excite the pyloric rhythm.
In this article we examine the fate of exogenously applied
proctolin in the nervous systemof the crab Cancer borealis.We
have found, in biochemical experiments using the relatively
large thoracic ganglion (TG), that proctolin is enzymatically
degradedprimarily by an aminopeptidase(AP) inhibitor-sensitive process. In complementary electrophysiological experiments,AP inhibitors enhancedthe excitatory effectsofproctolin
on the pyloric rhythm, suggestingthat AP activity terminates
the proctolin effects in the STG.
Portions of this work were published previously in abstract
form (Coleman et al., 1991).
Materials and Methods
Animals. Cancer borealis were obtained from Neptune Seafood & Lobster Co. (Boston, MA). Crabs were maintained in refrigerated (1 O-l 2”C),
aerated aquaria with filtered, circulating artificial seawater. Data were
obtained from 72 male crabs weighing between 300 and 800 gm.
Solutions. C. borealis physiologi&l &line contained (mmol/l&r) NaCl,
440: KCl. 11: M&l,. 26: CaCl,. 13: Trizma base. 10: and maleic acid.
5 (pH 7.4-7.5). ?r&ol&
and-ihe ‘AP inhibitors amastatin, bestatinl
epiamastatin, and puromycin were obtained from Sigma Chemical Co
(St. Louis, MO). The AP inhibitors arphamenine B and actinonin were
obtained from Peninsula Labs (Belmont, CA). Proct. [2-51 (Tyr-LeuPro-Thr) and Proct. [3-51 (Leu-Pro-Thr) were provided by Dr. James
M. Weimann (Department of Biology, Brandeis University), and were
synthesized using the procedure for peptide synthesis described in Weimann (1992). Proct. [l-2] (Arg-Tyr) and additional Proct. [3-51 were
synthesized by Research Genetics, Inc. (Huntsville, AL). All peptides
and peptidase inhibitors were stored either as frozen or lyophilized
aliquots of stock solution (1O-2 M or 10m3 M) that were diluted to the
working concentration in saline immediately before they were used.
Ganglionic incubations. Because a large source of neural tissue was
necessary to cleave amounts of proctolin large enough to be detected
by absorbance at 206 nm, we used the TG in these experiments. After
each dissection, the sheathed TG was pinned to a Sylgard (Dow Coming)coated petri dish and preincubated for at least 30 min in 3 ml saline.
Following several rinses, the TG was then incubated with either (1)
saline, (2) saline plus Proct. or Pro&. [2-51 (Peptide; 1O-5 M), or (3)
saline plus peptide ( 10m5 M) and peptidase inhibitor ( 1O-4 M). Each TG
incubation was maintained for at least 2 hr (1 l-l 5“C) and 220 pl aliquots
were removed at T = 1, 60, and 120 min. At T = 0 min, the aliquot
contained 2.2 x 10m9 mol of proctolin. Aliquots immediately received
25 ~1 of HCl (1 .O M) to inactivate enzymatic activity and were then
analyzed by reverse-phase high-performance liquid chromatography
(HPLC; see below).
Conditioned saline incubations. Incubations of TG to generate conditioned saline (CS) involved a 30-60 min preincubation with saline,
which was replaced with fresh saline (3 ml) for a subsequent 2 hr incubation. This CS was then removed and incubated with the same test
solutions described above for TG incubations. All incubations of CS
aliquots were performed at 13°C. Each CS aliquot was a 700 ~1 solution
of CS (560 ~1) and peptide (1 Om4M, 70 ~1) plus either peptidase inhibitor
(lo-’ M) or saline (70 ~1). Final concentrations in each aliquot were 1O-5
M peptide and 10m4 M inhibitor (when present). From each aliquot,
HPLC samples (220 ~1) were removed at T = 1, 60, and 120 min, and
immediately inactivated by adding HCl (1 .O M, 25 ~1).
HPLC. All HPLC analyses were performed using a Rabbit HPX Dual
Pump Delivery System with a Dynamic Mixer (Rainin) controlled by
a Macintosh SE computer using Dynamax HPLC METHOD MANAGER (version 1.3, Rainin). Sample volumes (200 ~1) contained 180 ~1 of CS

solution plus 20 ~1 of HCI. These samples were analyzed with a Vydac
C,, HPLC analytical column (0.46 x 25 cm, 300 8, pore size) to which
was fitted a Vydac C,, guard column and a precolumn filter. Samples
were analyzed with 0. II trifluoroacetic acid (TFA, pH 2; Aldrich) using
a linear gradient of acetonitrile (CH,CN) of 0.2-39% in 13 min (3%/
min), at a flow rate of 1.O ml/min. Peaks were detected at 206 nm using
a Knauer variable wavelength UV detector that was controlled by the
METHOD
MANAGER
software. Control injections were made of synthetic
peptide and peptidase inhibitors to verify retention time and to approximate the amount of material producing each peak of interest.
Detection threshold for proctolin was approximately 2 x lo-l2 mol.
In corn&ration experiments, material corresponding to peaks of interest was collected during the linear gradient using a Dynamax FC-2
fraction collector (Rainin). Purified samples were dried (SpeedVac Concentrator, Savant) and resuspended in HPLC solution A (99.7% H,O,
0.2% CH,CN, and 0.1% TFA). These samples were analyzed by HPLC
using the same C,, column and solvents, but under isocratic conditions.
The isocractic condition for Proct. [2-51 was 18% CH,CN, while for
Proct. [3-51 it was 14% CH,CN. Each resuspended fraction was halved
and the following injections were made to examine each peak of interest:
(1) half of the collected peak alone, (2) an approximately equivalent
amount of the putative synthetic analog, and (3) a mixture containing
the other half of the collected peak and an approximately equal amount
of the synthetic analog. To confirm sample identity and purity, after
isocratic elution, each peak of interest was analyzed also using the original linear gradient. As a final test of sample purity, the Proct. [2-51
peak was collected again, dried, and resuspended for HPLC analysis
under isocratic conditions using a second solvent system with triethylamine (TEA, pH 4.5; Pierce, Inc.) rather than TFA as the counter ion.
With this solvent system, Proct. [2-51 was assayed at 13% CH,HN.
HPLC data analysis. All chromatograms were stored for analysis
using Dynamax METHOD MANAGER software. The peak areas for the four
peaks of interest-proctolin
and the three degradation products-were
entered into spreadsheets for further analysis using LOTUS l-2-3, and
then were imported into SIGMAPLOT
(version 4.1) for graphic representation. In most cases, data were normalized by representing each peak
of interest as a percentage of the summed peak area of all four peaks.
However, this analysis was complicated by the fact that three of the
peptidase inhibitors used for these studies shared retention times with
one or another of the four peaks of interest. Thus, arphamenine B had
the same retention time as Proct. [3-51, puromycin the same as Proct.
[2-51, and epiamastatin the same as proctolin on the TFA linear gradient. Therefore, some data are also represented as the absolute peak
areafor eachpeakof interest.All backgroundpeakswith the same
retention time as Proct. and the Proct. fragments were subtracted from
the peaks of interest before analysis and graphic representation. Background peaks were identified as those peaks that were present, with
invariant size at all time points, in CS alone aliquots.
Electrophysiology. Electrophysiological experiments were performed
on the isolated STNS, which includes the COGS, OG, and STG, plus
their connecting and motor nerves (Fig. 1). The nervous system was
pinned down in a Sylgard-coated petri dish, and was superfused continuously with chilled (10-14”(Z) physiological saline at a rate of 7-12
ml/min. Impulse activity from the COGS to the STG was blocked by
applying isotonic sucrose (7.5 x 10-l M) to a Vaseline well surrounding
each desheathed COG (Fig. 1). The STG was superfused separately from
the OG and all nerves by surrounding the STG with a Vaseline well
that held approximately 0.5 ml saline (Fig. 1). Bath volume was approximately 10 ml.
The activity of the pyloric motor pattern produced by the STG was
monitored continuously by extracellular recordings from identified STG
motor nerves (Nusbaum and Marder, 1989a). Extracellular recordings
were made using stainless steel wire electrodes that were pressed into
the Sylgard alongside individual motor nerves and isolated from the
bath by Vaseline.
To examine the effects of coapplication of proctolin and peptidase
inhibitor to the STG, saline superfusion in the STG compartment was
stopped, and the saline was first replaced with 500 ~1 of either saline
alone or peptidase inhibitor ( 1O-5 M) dissolved in saline, and then incubated for 10 min (incubation 1). Saline alone was then replaced by
either saline alone or proctolin (lo-* M or lo-’ M) dissolved in saline
(500 pl) and again incubated for 10 min (incubation 2). Similarly, peptidase inhibitor saline was replaced by a saline solution (500 ~1) containing the same peptidase inhibitor ( 1O-5 M) plus proctolin ( 1Om8M),
and incubated for 10 min (incubation 2). After the second incubation,
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saline superfusion was resumed for 45 min. During test incubations,
the temperature in the STG compartment never increased by more than
3°C relative to the temperature in the outer compartment or that occurring during saline superfusion of the STG compartment.
Electrophysiology data analysis. Data were analyzed during the final
minute of each application. We characterized how proctolin influenced
the pyloric motor pattern by monitoring the pyloric cycle frequency and
the number of spikes per burst in the lateral pyloric (LP) motor neuron.
Cycle frequency was calculated as the reciprocal of the duration from
the first spike in a pyloric dilator (PD) neuron burst to the first spike
in the next PD neuron burst. Each analyzed segment is an average of
either the cycle frequency or the number of LP spikes per burst over
10 consecutive cycles. In some experiments (N = 5) proctolin (lo-’ M)
caused little (~0.1 Hz) or no increase in pyloric cycle frequency. We
did not include the results from these experiments in our analysis of
changes in cycle frequency during application of different peptidase
for graphic represeninhibitors. All data were entered into SIGMAPLOT
tation.
Statistics. All statistical analyses were performed using GBSTAT (version 3.0). Statistical significance was determined by using either Student’s t test or, for three or more test conditions, analysis of variance
(ANOVA). Tukey’s t test was used for post hoc multiple comparisons
of ANOVA, with a critical level of a = 0.05. All data are presented as
mean + standard deviation (SD). Statistical analyses of the data in
Tables 2-5 were performed by comparing the difference between incubation 2 and incubation 1 for each experimental condition relative
to this difference for the control condition (lo-* M or lo-’ M proctolin
in saline without any inhibitors, as indicated in each table).
The proctolin data from Tables 2 and 3, and those from Tables 4
and 5, were obtained from separate experiments. In each case, the proctolin data were obtained from the same preparations as were the other
data in the same table.

Results
Proctolin degradation
Incubations
of proctolin with the TG, followed by HPLC analysis of aliquots of the incubate at 1,60, and 120 min time points,
revealed that the amount of proctolin
present in the incubate
diminished
over the course of 2 hr (N = 4; Fig. 2A). In contrast,
when the same amount of proctolin
was incubated under the
same conditions with saline alone, the size ofthe HPLC-detected
proctolin peak remained constant over a 2 hr period (not shown).
In parallel with the reduction in the size of the proctolin peak
during TG incubations
there appeared three novel HPLC-detected peaks, called putative proctolin
fragments l-3 (PPF- 1,

PPF-2, PPF-3) which increasedin size with incubation time
(Fig. 2A). Thus, at T = 1 min, nearly all (97%) of the analyzed
peak area resulted from proctolin. At T = 120 min, only 82%
of this area was due to the proctolin peak and the remaining
18% resulted from the PPF peaks. The concomitant decrease
in the proctolin peak and increasein three novel peakssuggested
that proctolin wasbeing degradedby the TG and that the novel
peaks were the resulting proctolin degradation products (see
below).
PPF-1, the largest of the three novel HPLC-detected peaks,
had a retention time on the linear gradient of 13.3 min, and
thus eluted immediately
before the proctolin peak, which had
a retention time of 13.7 min (Fig. 2). PPF-2 and PPF-3 had
retention times of 11.9 min and 10.6 min, respectively (Fig. 2).
Generally, no PPF-2 or PPF-3 was detected in the T = 1 min
aliquot. In contrast, the T = 1 min aliquot routinely showed a
small but discernable peak at the PPF- 1 retention time (Fig. 2).
This peak, however, resulted from background
absorbance as
it was also present in control (CS alone) HPLC injections (Fig.
2B, top trace).

We examined the extent to which the proctolin-degrading
activity

was released

into the saline. To this end, we produced

Figure 1. Schematic diagram of the stomatogastric nervous system
(STNS) of the crab Cancer borealis. The paired commissural ganglia
(COG) were surrounded by Vaseline wells (heavy lines) and the saline
inside the wells was replaced with isotonic sucrose (7.5 x 10-l M). The
stomatogastric ganglion (STG) was surrounded by a separate Vaseline
well. The STG was superfused separately from the remainder of the
STNS. Shaded region in each ganglion represents the neuropil. In the
STG, the neuropil is surround by the neuronal somata. Three lines
entering the neuropil represent the axons of neurons innervating the
STG from COGS and OG. dgn, dorsal gastric nerve; dvn, dorsal ventricular nerve; ion, inferior esophageal nerve; fvn, lateral ventricular
nerve; mvn, medial ventricular nerve; OG, esophageal ganglion; son,
superior esophageal nerve; stn, stomatogastric nerve.

conditioned saline from the TG, after which this CS was incubated with proctolin (seeMaterials and Methods; N = 20).
Similar to its incubation with the TG, the proctolin peak diminishedover time with CSincubation and the samethree novel
peaks were the only nonproctolin peaks to change with time
(Fig. 2B). Surprisingly, the CS was as effective in degrading
proctolin as was incubating the peptide directly with the TG
itself (p > 0.05 Table 1). As shown by the aggregatedata (N =
20) in Figure 3, the amount of each PPF produced in CS at
T = 60 min and 120 min was significantly

greater

than that

produced at T = 1 min. At all time points, the size of the PPF- 1
peak wasgreater than either of the other two novel peaks.Concomitantly, there was a significant reduction in the proctolin
peak at theselater time points. Thus, the amount of the initial
proctolin aliquot (1.8 -t 0.15 nmol) remaining at T = 60 min
was 1.66 f 0.12 nmol, while there was 1.55 + 0.14 nmol remaining at T = 120 min. For theseexperiments, during the 120
min incubations, the proctolin degradation rate was approximately 0.19 nmol/liter/sec
The ability of the TG to produce conditioned saline that
effectively degradedproctolin was not limited to the first 2 hr
incubation. In three experiments, three successiveconditioned
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Figure
2. Proctolin (1O-5 M) degradation resulting from incubation with the TG (A) and conditioned saline (C’S, B). In each case, HPLC
chromatograms show proctolin degradation at different time points. With increasing incubation time, the putative proctolin fragment (PPF) peaks
increased in size. All unlabeled peaks are background peaks that are unrelated to proctolin. Peakswereanalyzedat 206nm. Peak3, PPF-3(RY);
penk2, PPF-2(LPT); peak I, PPF-1(YLPT); peakP., proctolin(RYLPT = Arg-Tyr-Leu-Pro-Thr).

salineswere produced, each one involving a 2 hr incubation
with the same TG (Fig. 4). In each of these experiments, we
found that CS 3 was essentiallyaseffective as CS 1 in reducing
the size of the proctolin peak and increasingthe size of the PPF
peaks on HPLC.

Idenbjication of proctolin degradation products
We reasoned, by comparing the above results with those of
earlier studiesof proctolin degradation in insect neural tissue
(Quistad et al., 1984; Isaac, 1987), that the PPFs were likely to
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Figure 3. Mean proctolin and PPF peak areas with increasing incubation time in CS (N = 20). With increasing incubation time, the percentage of the total peak area due to proctolin decreased while it increased for the PPFs. Note the different scale on the ordinate for the
PPF peaks and the proctolin peak. Data are plotted as percentage of
total peak area, with 100% equal to the sum of the peak areas of PPF3, PPF-2, PPF-1, and Proct.; **, p < 0.01 compared to T = 1 min
(ANOVA), for each peak of interest. Abbreviations are the same as in
Figure 2.

be Proct. [2-51 (PPF-1), Proct. [3-51 (PPF-2) and Proct. [l-2]
(PPF-3). To determine if this wasindeedthe case,we performed
HPLC comigration experiments and compared the retention
times of purified PPF-1 and PPF-2 with synthetic analogs(see
Materials and Methods). It was difficult to collect and purify
sufficient PPF-3 for comigrations, so we compared the HPLC
retention time of PPF-3 and synthetic Proct. [l-2] (seebelow).
Purified PPF-1 did indeed corn&rate with synthetic Proct. [25], both under isocratic conditions (N = 5; Fig. 5A) and with a
linear gradient (data not shown). Similarly, PPF-2 comigrated
with synthetic Proct. [3-51 under isocratic conditions (N = 5;
Fig. 5B). To verify further the identity of PPF-1, we used a
second solvent system that used TEA in place of TFA as the
counter-ion (seeMaterials and Methods). Under these conditions, PPF-1 again comigrated with Proct [2-51 (not shown; n
= 3). Recovery of PPF-2 was insufficient for accurate analysis
with the TEA solvent system.In parallel HPLC injections, using
the TFA linear gradient, synthetic Proct. [l-2] had the same
retention time as PPF-3.
Proct. [l-2] and Proct. [3-51 could have beencoproduced by
a singlediaminopeptidase(DAP)-mediated cleavage.Proct. [35], however, could also have been produced by AP cleavageof
Proct. [2-51. To study this latter possibility, we incubated synthetic Proct. [2-51 (7 x 10m9mol) both with the TG and with
CS, using the sameprotocols and HPLC analysisthat were used
for proctolin incubations. Both TG (N = 3; data not shown)and
CS (N = 4; Fig. 6) degradedProct. [2-51 and produced Proct.
[3-51. After 2 hr CS incubations, 94.3 f 2.2% of the total peak
area was Proct. [2-51 (Fig. 6) as compared with approximately
88% being due to the proctolin peak (Table 1) after comparable

2

10

0

. 0
w
PPF-3
@$$j PPF-2

m

cs:12

3

PPF-1
Proct.

Figure 4. Proctolin (10m5 M) degradation by sequentially generated
conditioned salines from the TG, assayed after incubations of 120 min.
Data are plotted as the percentage of the total peak area of the proctolin
and PPF peaks. All three conditioned salines were from normal Cancer
saline. N = 3; p > 0.05 (ANOVA), for comparisons of corresponding
peaks in all three incubations.

proctolin incubations. Thus, after these 2 hr incubations, aliquots contained 1.59 f 0.07 nmol of Proct. [2-51, while aliquots
at T = 0 min contained 1.80 f 0.19 nmol. This resulted in a
degradation rate of approximately 0.22 nmol/liter/sec, which
was similar to the proctolin degradation rate (0.19 nmol/liter/
set). As shown in Figure 6, there were increasingamounts of
Proct. [3-51 produced over the course of the 2 hr incubations.
Thus, Proct. [3-51 could be produced by serialN-terminal cleavageof proctolin. In contrast to the proctolin incubation experiments, no Proct. [l-2] was produced from the Proct. [2-51
incubations.
Aminopeptidaseinhibitors diminish proctolin degradation
Proctolin had beenshownto be sensitiveto AP activity (Quistad
et al., 1984;Isaac, 1987) so we testedthe ability of six different
AP inhibitors to prevent proctolin degradationby CS. As shown
in Figures 7 and 8, each AP inhibitor that we tested was able
to prevent at least partially the reduction in the size of the
proctolin peak and/or the appearanceof one or more of the
proctolin fragment peaks. For the inhibitors amastatin, actiTable 1. Proctolin degradation during CS incubation versus TG
incubation (O/ototal peak area at T = 120 min)

CS (N = 20)
TG(N=4)

PPF-3
fRY)
\ ,

PPF-2
ILPT)
\
,

PPF- 1
(YLPT)
\
,

Proct.
(RYLPT)

0.6 k 0.2
0.9 f 0.2

1.1 * 0.5
3.5 k 1.4

10.2 f 4.2
13.3 + 4.9

88.1 + 4.8
84.2 -t 4.2

p > 0.05, Student’s t test, for comparison of each peak in TG versusCS.
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Figure 5. Corn&ration of proctolin
degradation products and their synthetic analogs: HPLC chromatograms
under CH,CN isocratic conditions, following collection from CH,CN linear
gradient using TFA as the counter-ion
(see Materials and Methods) for synthetic Proct. [2-S] and PPF-1 (A), and
synthetic Proct. [3-51 and PPF-2 (II).
Al, Half of synthetic Proct. 12-51 fraction collected from linear gradient. A2,
Half of PPF-1 fraction collected from
linear gradient following proctolin incubation in CS. A3, Combination of
second half of synthetic Proct. [2-51 and
second half of PPF-1 from proctolin
degradation in CS. BI, Half of synthetic
Proct. [3-51 fraction collected from previous TFA linear gradient. B2, Half of
PPF-2 fraction collected from previous
TFA linear gradient following proctolin
incubation in CS. B3, Combination of
halfof synthetic Proct. [3-51 and PPF-2
fractions. Arrowsindicate peaks of interest. Unlabeled peaks are solvent front
and background peak.

nonin, and bestatin, we quantitatively analyzed the fraction of
the initial amount of proctolin that was found in the form of
proctolin, Proct. [2-51, Proct. [3-51, and Proct. [l-2] after 2 hr
co-incubations of CS with proctolin and each inhibitor (Fig.
8A). Becauseof overlap of HPLC retention times with peaksof
interest, data for the other three inhibitors could only be analyzed aspeak areas(seeMaterials and Methods; Fig. 8B). When
we compared thesepeakswith those resulting from incubation
of proctolin without inhibitor, we found that each of these inhibitors significantly decreasedthe amount of proctolin degradation (Fig. 8). In terms of the size of either the proctolin peak
or that of Proct. [2-51, amastatin and actinonin were equally
effective and were more effective than bestatin. For example,
after 2 hr incubations, 88% of the total peak area wasproctolin
when no inhibitors were present, while 93% wasproctolin when
bestatin was also present and 98% was proctolin when either
amastatin or actinonin was present (Fig. 8A).
Interestingly, the ability of each inhibitor to prevent the appearanceof Proct. [2-51 did not necessarilycorrelate with the
ability of that inhibitor to block the appearanceof Proct. [3-51
and Proct. [l-2]. Thus, relative to CS alone, only actinonin
significantly reduced the amount of both Proct. [3-51 and Proct.
[l-2] (Figs. 7, 8). While amastatin alsosignificantly reducedthe
size of the Proct. [3-51 peak, it did not change the size of the
Proct. [l-2] peak relative to CS alone (Figs. 7, 8). Additionally,
whereasbestatin and arphameninehad little influence on Proct.
[3-51, their presenceproduced a slight increasein the Proct. [l21peak size (Fig. 8B). Puromycin did not alter the size of either
the Proct. [3-51 or Proct. [l-2] peaks.
Like proctolin degradation, the Proct. [2-51 degradation was

also amastatin sensitive. Thus, after 120 min co-incubations of
Proct. [2-51 plus amastatin in CS, the Proct. [2-51 peak was
indistinguishable from that of controls (percentagetotal peak
area, 99.1 f 0.2%; N = 4) and only trace amounts (< 1%) of
Proct. [3-51 were detected. In contrast, approximately 6% of the
peak area was representedby the Proct. [3-51 peak after 120
min incubations of Proct. [2-51 with CS alone (Fig. 6). This
amastatin-sensitivedegradation of Proct. [2-51 presumably accounts for the decreasein the Proct. [3-51 peak that occurred
from proctolin incubations in CS plus amastatin. No other inhibitor was tested on Proct. [2-51 degradation.
Proctolin actions are enhancedby aminopeptidaseinhibitors
To test the physiological role of the AP activity identified in
our biochemical studies, we examined the ability of the AP
inhibitors used in these biochemical studies to influence the
modulatory effectsof proctolin on the pyloric motor pattern in
the stomatogastric ganglion. The experimental setup is illustrated in Figure 1and isdescribedin the Materials and Methods.
We reasonedthat if the AP inhibitors effectively prevented proctolin degradation, then they should enhancethe proctolin-mediated excitation of the pyloric motor pattern in the STG. To
test this hypothesis, we applied eachAP inhibitor (1O-5M) with
proctolin (1Om8M). As predicted, many of these inhibitors did
enhance the proctolin excitation of the pyloric motor pattern
(Figs. 9, 10; Tables 2, 3: incubation 2 vs 1). In contrast, none
of these inhibitors influenced the pyloric motor pattern when
applied alone (Tables 2, 3: incubation 1). The enhancedexcitation that occurred when theseinhibitors were coapplied with
proctolin included (1) a faster pyloric motor pattern, and (2)
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Figure 6. Proct. [2-S] (lOmsM) is degradedduringincubationswith
CS from the TG. The percentage
of the total peakarea(Proct. [2-51
plusProct. [3-51)dueto Proct. [2-51decreased
whilethat dueto Proct.
13-51increasedwith increasingincubationtime. N = 4: **. D < 0.01:
i, p 2 0.05;comparedto T = lmin (ANOVA) for eachpeakofinterest:
Dataare plottedasin Figure3.
more intense impulse bursts in several pyloric neurons. For
example, in the experiment shown in Figure 9, bestatin only
slightly enhanced the proctolin-mediated excitation of the pyloric rhythm, but amastatin increasedthis activity such that it
was equivalent to that occurring in the presenceof a IO-fold
higher concentration of proctolin. Only the peptidaseinhibitors
amastatin and arphamenineB significantly increasedthe pyloric
cycle frequency relative to proctolin (1Om8M) alone (Table 2).
While the effects of actinonin on cycle frequency appearedto
be comparably large, they were only studied in two experiments
(Table 2). In contrast, all five inhibitors enhancedthe number
of LP neuron impulses per burst as compared with proctolin
( 1O-8M) alone (Fig. 10, Table 3). Bestatin and arphamenineB,
however, were lesseffective than actinonin, epiamastatin, and
amastatin, all of which enhancedthe effectsof lo-* M proctolin
on LP neuron activity such that it was indistinguishablefrom
that resulting from application of lo-’ M proctolin (Fig. 10,
Table 3).
Physiological actions of proctolin degradationproducts
To test whether the observed proctolin cleavageswere inactivating the peptide, we studied the effects on the pyloric motor
pattern of bath applying each identified proctolin degradation
product to the STG. As shown in Figure 11, when we applied
Proct. [2-51 in the concentration rangewhere the parent peptide
effectively excites the pyloric rhythm ( 10m9M to 1O-6M), there
was no effect on this motor pattern. However, higher dosesof
Proct. [2-51 (> 10m6M) did excite the pyloric rhythm (n = 3-5).
This effect was moderately strong for applications of 1O-5 M
Proct. [2-51 and it was particularly strong for applications of 5
x 1O-5 M (Fig. 11). These latter effects were indistinguishable
from those of lower dosesof the parent peptide (lo-’ M proctolin; Fig. 1, Tables 4, 5). In contrast to the resultswith Proct.

0

CS + Proct. 2
w/Amast.
$

./..

. . . _. _..

time (min.)

,
19

Figure 7. Proctolin degradationin the presenceof differentaminopeptidaseinhibitors: HPLC chromatograms
of aliquotsof proctolin
(1O-5M) plusor minusaminopeptidase
inhibitor (10m4
M) in CS, after
incubationfor 120min (T = 120min). The sizeof the proctolinpeak
andthat of peakI wereboth reducedwith aminopeptidase
inhibitors
presentwhencompared
with CSplusproctolinalone.Additionally,peak
2 wasreducedby amastatinand actinonin,whilepeak3 wasreduced
by actinonin.Best.,bestatin;Actin., actinonin;Amast.,amastatin;Proct.,
proctolin.
[2-51, bath application of even higher doses( 10e4M) of Proct.
[l-2] and Proct. [3-51 had no effect on the pyloric rhythm (N
= 4; data not shown).

Discussion
Proctolin degradation by conditioned saline
In this study we have shown that the pentapeptide proctolin is
cleaved by the crab nervous system. This cleavageis mediated
primarily by AP activity, although there appearsto be some
DAP-like activity as well. Surprisingly, we found that saline
preincubatedwith the TG had nearly asmuch proctolin-cleaving
activity as the TG. Thus, nearly all of the proctolin-cleaving
activity wasprobably releasedinto the extracellular spacerather
than remaining tightly bound to ganglionic membranes.
There are several possibleexplanations for the generation of
proctolin-degrading activity in the CS. For example, this activity
might have resultedfrom exocytosis. Alternatively, the activity
might have been tethered to the extracellular surfaceof ganglionic membranesby a labile linkagethat wascontinually cleaved.
Neither of thesepossibilitieswasexamined in our experiments.
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8. Summary of effectiveness of different aminopeptidase inhibitors on CS-mediated proctolin degradation. A, Percentage of total peak area
represented by each of the proctolin-related
peaks. Data were collected following proctolin incubation ( 1O-5 M) with CS plus or minus an aminopeptidase inhibitor (10m4 M) at T = 120 min. For each condition, data are plotted as the mean peak area for each peak divided by the mean total
area for the four proctolin-related
peaks. B, Mean peak area of proctolin and each proctolin fragment after CS incubation of proctolin (1O-5 M),
plus or minus an aminopeptidase inhibitor (1O-4 M; T = 120 min). Data for no inhibitors, bestatin, actinonin, and amastatin are replotted from
A. Missing
bars indicate values for which the inhibitor shared the same retention time as the peak of interest. Overlapping peaks are arphamenine
B and Proct. [3-51, puromycin and Proct. [2-S], and epiamastatin and proctolin. Statistical analysis indicates significantly different than CS with
no inhibitors within each peak of interest: **, p < 0.01; *, p < 0.05; ANOVA.
Figure

However, there is precedencefor the latter possibility in that
other cell surface enzymes, including acetylcholinesterase,are
membraneanchored via a phospholipaseC-sensitive, glycosylphosphatidylinositol linkage (Futerman et al., 1985;Haas et al.,
1988; Low and Saltiel, 1988). Such a linkage also exists for at
least one AP, aminopeptidase P (AP-P, EC 3.4.11.9; Hooper
and Turner, 1988).
Multiple proctolin-degrading enzymes?
Our results are consistent with proctolin cleavage in the crab
nervous system being mediated by at least two different enzymes. The major proctolin-degrading activity appearsto be an
AP, since most of the proctolin cleavage is suppressedby AP
inhibitors, and our HPLC comigration experimentsindicate that
the major
[2-51.

AP inhibitor-sensitive

degradation

product

is Proct.

The secondproctolin-degrading activity appearsto be a DAP.
This conclusion is basedprimarily on the coappearanceof Proct.
[l-2] and Proct. [3-51 in proctolin incubations
with either CS
or TG. While Proct. [3-51 was also produced via serial, AP
inhibitor-sensitive

cleavages of proctolin,

the larger source of

Proct. [3-51 generation appearedto be cleavageof the Tyr-Leu
bond via DAP activity. This interpretation is supported by the
observation that in most of the proctolin co-incubations with
AP inhibitors, the sameamounts of Proct [3-51 and Proct. [l21weregeneratedaswithout any inhibitor present,even though
Proct. [2-51production wasreducedsignificantly. The DAP-like
activity, however, can only account for about 20% of the total

proctolin degradation, becauseapproximately 80% of the proctolin degradation is eliminated in the presenceof the AP-inhibitor amastatin.
Identity of the proctolin-cleaving peptidases
Previous workers (McDonald and Barrett, 1986; Turner et al.,
1989) have characterized four distinct mammalian APs that
show somesimilarity to the proctolin-cleaving activity that we
have described in the crab nervous system. These include leutine AP (LAP; EC 3.4.1 l.l), aminopeptidase M (AP-M; EC
3.4.11.2), aminopeptidaseB (AP-B; EC 3.4.11.6), and aminopeptidaseA (AP-A, EC 3.4.11.7). Each of thesepeptidasesexhibits different substrate and inhibitor specificities. Of these
enzymes, the likeliest ones to degradeproctolin effectively are
LAP, AP-M, and AP-B. Purified mammalian LAP has been
shown to cleave proctolin effectively in solution, although the
cleavage products were not identified (Brown, 1977; Davis et
al., 1989). The preferred substratesfor both AP-M and AP-B
include peptides,suchasproctolin, with an N-terminal arginine
(McDonald and Barrett, 1986;Turner et al., 1989).Each ofthese
APs, however, hasbeenreported to have an inhibitor-sensitivity
profile that is distinct from that of the proctolin-sensitive AP
activity seenby us in the crab (Umezawa and Aoyagi, 1983;
McDonald and Barrett, 1986). It is, however, possiblethat the
AP activity in our study representsseveral different enzymes
with overlapping inhibitor sensitivities, rather than a singleAP.
Supporting this possibility is our finding that the crab AP ac-
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Figure 9. Effects of bath-applied

aminopeptidase

inhibitors

(lo+

M) on the excitatory effects of proctolin (lo-* M) on the pyloric motor pattern.

Activity of an ongoingpyloric motor patternfrom a singleexperimentis monitoredby extracellularrecordingsof a pyloric motor nerve,the dvn
(seeFig. 1).LP, lateralpyloric constrictormotor neuron;PY, pyloric constrictormotor neuron;PD, pyloric dilatormotor neuron.
tivity was approximately equally inhibited by amastatin, actinonin, puromycin, and epiamastatin.
Previous work in the insect nervous system showedthat extracellular proctolin is a substrate of AP activity and that its
degradation was most effectively inhibited by amastatin (Quis-

Table 2. The effect of aminopeptidase inhibitors on the proctolinmediated excitation of the pyloric rhythm cycle frequency (Hz)

Saline
superfusion

Incubation

1 Incubation 2

Saline (n = 5)

0.45 + 0.2

0.47 + 0.2

lo-* Mproctolin(n = 9)

0.46 f 0.2

0.47 + 0.1

Bestatin (n = 7)

0.39 -t 0.2
0.48 zk 0.1

Amastatin (n = 5)

0.54 z!z0.4
0.47 f 0.1

0.44
0.48
0.38
0.63
0.47

lo-’ M pro&Olin(n = 5)

0.42 + 0.2

0.45 +- 0.2

Epiamastatin
(n = 5)
ArphamenineB (n = 5)
Actinonin (n = 2)

0.39 * 0.1

IL
+
-t
f
+

0.2
0.2
0.2
0.4
0.1

0.46
0.54
0.50
0.55
0.49
0.72
0.61

iz 0.2t
+ 0.2t
z!c0.2t
+ 0.2t
z!r 0.2*
Z!I0.2
+ O.l*

0.66 & 0.2*

“Incubation 1” indicates STG incubation with either saline (for saline, 10-O M
proctolin, and lo-’ M pructolin) or aminopeptidase inhibitor (10-l M, for all
others). “Incubation 2” indicates STG incubation with incubate 1 plus either
saline (for saline), lo-’

M proctolin

(for IO-’ M proctolin),

or lo+

M proctolin

(for all others). See Materials and Methods for further details.
* Value is significantly
Student’s t test.
t Value is significantly

Student’s t test.

different
different

from
from

lo-*
lo-’

ki proctolin
M proctolin

tad et al., 1984; Isaac, 1987). However, other aspectsof the
inhibitor profile determined by Isaac (1987) for the proctolincleaving AP activity of insect neural membrane fractions differed from that of the AP activity describedin the presentstudy.
Proctolin wasalso degradedby DAP activity in theseprevious
studies,although the particular DAP responsiblefor this degradation was not identified (Quistad et al., 1984; Isaac, 1987).
However, Hui (1988) reported that proctolin is readily cleaved
by DAP V. DAP V, purified from rat brain membranes,strongly
prefers peptides with an arginine residue at the N-terminus,
including proctolin.

application:
application:

p < 0.05,

Table 3. The effect of aminopeptidase inhibitors on the proctolinmediated excitation of the LP neuron (spikes per burst)
Saline
sunerfusion
4.4 + 1.4
Saline (n = 8)
lo-* h3proctolin(n = 12) 4.2 k 1.5
Bestatin(n = 8)
5.3 + 2.8
4.2 f 1.6
Arphamenine B (n = 7)
Actinonin (n = 4)
5.3 z!z 3.4
Epiamastatin
(n = 5)
4.1 f 1.4
Amastatin(n = 11)
5.0 f 1.5
lo-’ M proctolin (n = 8) 4.8 f 1.9

p c 0.05,

Details are as for Table 2.

Incubation
4.4
4.3
5.6
3.6
5.6
4.0
5.5
4.5

f 1.6
+ 1.7
-+ 3.3
rt 2.0
+- 2.6
J- 2.1
z!I 2.0
rfi 2.1

1 Incubation 2
4.3
6.6
9.1
8.0
11.2
9.9

+ 1.6*+
f 2.7t
f 3.4*t
+ 2.5*t
zk 3.2*
IIZ3.2*

11.6* 2.9*
12.6 I!I 3.5*
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Figure 10. Cumulativeresultsof the influenceof differentaminopep-

tidaseinhibitorson the proctolin-mediated
changesin the numberof
LP neuronimpulsesperburst.Datarepresentthemeandifferencefrom
applicationof eithersaline(saline,1O-8M Proct., lo-’ M Proct.)or the
relevantinhibitor. Eachinhibitor (1O-5M)wasfirst appliedalone,and
then immediatelycoappliedwith proctolin( 1O-8M). S, saline(n = 8);
(n
IO-p M Pr, proctolin (n = 12);B, bestatin(n = 8); Ar, arphamenine
(n = 5); Am, amastatin(n
= 8); AC, actinonin(n = 4); E, epiamastatin
= 10); IO-’ M; Pr, proctolin (n = 8). *, p i 0.05 (relativeto lo-* M
Proct.); +, p < 0.05 (relativeto lo-’ M Proct.);Student’st test.

Physiological role of proctolin-cleaving peptidases
Our resultsareconsistentwith there beingextracellularly located
AP activity within the STG that terminates the neural actions
of proctolin. This conclusion is basedon the fact that the same
AP inhibitors that effectively suppressedproctolin degradation
in our biochemical experiments were able to enhancethe excitatory effects of bath-applied proctolin in our electrophysiological experiments. Although we analyzed the enzymatic degradation of proctolin using a different ganglion than we usedto
monitor its electrophysiological effects,the order of effectiveness
of the peptidase inhibitors used in both types of experiments
was similar.
In addition to the proctolin-degrading activity reported by us
to reside within the crab nervous system, there is previously

10”M

Proct.

‘,“,.r.,,l(.‘.I’,

.‘.I.‘.“.
Is

Figure II. Effectsof Proct. [2-51on the pyloric motor pattern.Bath
applicationof Proct. [2-51at ~10~~M to the isolatedSTG did not
influencethepyloric motor pattern.However,higherconcentrations
of
Proct.[2-5](5 x lo+ M) excitedthe pyloric motorpatternin a manner
similarto bathapplicationof proctolin(lo-’ M). Pyloric motorpattern
wasmonitoredby an extracellularrecordingof the dvn.All recordings
werefrom the samepreparation.
reported proctolin-degrading activity within the crustaceanhemolymph. Schwarz et al. (1984) reported that, in preliminary
experiments where they injected exogenousproctolin in the hemolymph of the lobster Homarus americanus, proctolin was
degradedwith a half-life of 6-10 min. Proctolin cleavagealso
occursin insect hemolymph (Steeleand Stat-rat& 1985). Because
the STG is located within a major artery, any neurally released
proctolin that was not degradedby ganglionic enzyme activity
would likely be degradedin the hemolymph. Our experiments

Table 4. The effect of Proct. [2-51 on the pyloric cycle frequency (Hz)

Saline(n = 6)
1O-8M proctolin(n = 7)
lo-’ M proct. [2-51(n = 3)
lo+ M proct. [2-51(n = 4)
1O-sM proct. [2-51(n = 4)
5 x lo+ M proct. [2-51(n = 5)
lo-’ r+4proctolin(n = 10)
Details

are as for Table 2.

Salinesuper-fusion Incubation1

Incubation2

0.49
0.59
0.55
0.55
0.47
0.56
0.53

0.55
0.63
0.64
0.64
0.65
0.79
0.76

f 0.04
AI 0.2
+ 0.1

+ 0.2
+ 0.2

k 0.1
zk 0.1

0.53 + 0.1
0.58 III 0.1
0.64 z!z0.1

0.61 + 0.2
0.56 + 0.1
0.61 f 0.2
0.61 + 0.2

* 0.1t
zkO.lt
rt O.lt
+ O.lt
xk 0.04
f 0.2*
f 0.2*
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Table 5. The effect of Proct. [2-51 on the number of spikes per burst in the LP neuron

Saline (n = 6)
lo-* M proctolin (n = 7)
lo-’ M proct. [2-51 (n = 3)
1O-6 M proct. [2-51 (n = 4)
1O-5 M proct. [2-51 (n = 4)
5 x 1O-5 M proct. [2-51 (n = 5)
lo-’ M proctolin (n = 10)

Saline superfusion

Incubation

4.3
4.9
3.8
4.3
4.6
5.7
4.3

4.4
5.1
3.4
4.6
4.4
4.5
4.6

+ 1.0
k 1.9
+ 2.5
-t 2.8
k 3.9
+- 2.4
k 2.7

*
+
+
+
*
f
k

0.7
1.7
2.0
2.5
3.1
2.3
2.3

1

Incubation 2
3.8
6.8
3.2
5.2
7.2
11.8
12.9

k 0.9t
+ 1.8t
f 1.1t
k 2.8t
+ 3.4-f
zk 1.7*
+ 3.2*

Details are as for Table 2.

do not enable us to predict which of thesetwo sourcesof proctolin-degrading activity would be larger.
We were surprised to find that proctolin was only approximately 500-fold more effective than Proct. [2-51 in exciting the
pyloric motor pattern. An earlier study by Starratt and Brown
(1979) using a proctolin-sensitive muscle assay,showed that
proctolin was > lo6 x more effective than Proct. [2-51. Whether
this difference results from different proctolin receptors, differential sensitivities to resident peptidases,or differential access
to receptors remains to be determined.
The proctolin degradation reported in the present study may
well contribute to the relatively short-lasting excitatory effects
of two proctolin-containing neurons, MPN and MCNl, on the
pyloric motor pattern in the crab STG (Nusbaum and Marder,
1989a,b; Nusbaum et al., 1992; Christie et al., 1993; Coleman
and Nusbaum, 1994). Whereassomemodulatory neuronshave
effectsthat long outlast their period of impulse activity (HarrisWarrick et al., 1992b), the effects of both MPN and MCNl
subsidewithin secondsafter their activity is terminated (Nusbaum and Marder, 1989a,b;Nusbaumet al., 1992). Becausethe
effectsof the proctolin neuronson the pyloric rhythm are equivalent to bath application of 10m7M to 1O-6 M proctolin and
threshold for proctolin actions on this system is approximately
1O-9M (Marder et al., 1986; Nusbaumand Marder, 1989b), the
local concentration of neurally releasedproctolin probably decreasesby 2-3 orders of magnitude within several secondsor
less.Sucha rapid decreasein local proctolin concentration would
be facilitated by the proctolin-cleaving actions identified in the
present study. Finally, since many extracellularly located peptidasescleave more than one neuropeptide (Turner et al., 1985;
Turner, 1987), it is possiblethat the peptidaseactivities documented in this study also degradeother neurally releasedpeptides in the crustaceannervous system.
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